Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lower Extremity | 5 | 2019 | 100 | 1.130 |
Why?
|
| After-Hours Care | 1 | 2019 | 6 | 0.680 |
Why?
|
| Hospital Costs | 1 | 2019 | 37 | 0.660 |
Why?
|
| Operating Rooms | 1 | 2019 | 35 | 0.660 |
Why?
|
| Patient Care Team | 1 | 2019 | 129 | 0.630 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2014 | 69 | 0.590 |
Why?
|
| Seroma | 1 | 2011 | 5 | 0.390 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 11 | 0.390 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2010 | 18 | 0.360 |
Why?
|
| Vena Cava, Inferior | 1 | 2010 | 30 | 0.360 |
Why?
|
| Sarcoma | 1 | 2010 | 73 | 0.340 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 88 | 0.340 |
Why?
|
| Hand Strength | 2 | 2020 | 101 | 0.320 |
Why?
|
| Vascular Diseases | 2 | 2020 | 66 | 0.310 |
Why?
|
| Accidental Falls | 1 | 2010 | 222 | 0.310 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2014 | 83 | 0.310 |
Why?
|
| Saphenous Vein | 2 | 2017 | 20 | 0.280 |
Why?
|
| Aged | 14 | 2020 | 10308 | 0.280 |
Why?
|
| Peritoneal Neoplasms | 1 | 2009 | 259 | 0.270 |
Why?
|
| Retrospective Studies | 8 | 2020 | 3505 | 0.260 |
Why?
|
| Male | 15 | 2020 | 19206 | 0.230 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2014 | 49 | 0.220 |
Why?
|
| Renal Artery Obstruction | 2 | 2014 | 41 | 0.220 |
Why?
|
| Vascular Patency | 3 | 2017 | 69 | 0.210 |
Why?
|
| Treatment Outcome | 7 | 2017 | 3305 | 0.200 |
Why?
|
| Middle Aged | 10 | 2019 | 11834 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 917 | 0.190 |
Why?
|
| Female | 14 | 2020 | 20002 | 0.190 |
Why?
|
| Humans | 17 | 2020 | 32086 | 0.190 |
Why?
|
| Time Factors | 4 | 2019 | 2145 | 0.180 |
Why?
|
| Risk Factors | 7 | 2020 | 3880 | 0.170 |
Why?
|
| Models, Economic | 1 | 2019 | 19 | 0.170 |
Why?
|
| Cost Savings | 1 | 2019 | 33 | 0.170 |
Why?
|
| Specialization | 1 | 2019 | 31 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2020 | 186 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 185 | 0.160 |
Why?
|
| Amputation | 1 | 2018 | 38 | 0.160 |
Why?
|
| Psoas Muscles | 1 | 2017 | 19 | 0.150 |
Why?
|
| Electronic Health Records | 1 | 2019 | 164 | 0.150 |
Why?
|
| Marital Status | 1 | 2017 | 23 | 0.150 |
Why?
|
| Aortography | 2 | 2014 | 16 | 0.140 |
Why?
|
| Sarcopenia | 1 | 2017 | 64 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2020 | 780 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2016 | 46 | 0.140 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2016 | 9 | 0.140 |
Why?
|
| Celiac Artery | 1 | 2016 | 6 | 0.140 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2016 | 12 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2017 | 115 | 0.140 |
Why?
|
| Angioplasty, Balloon | 1 | 2016 | 35 | 0.140 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 873 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2015 | 28 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2016 | 131 | 0.130 |
Why?
|
| Stents | 2 | 2016 | 177 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 52 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 127 | 0.120 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 684 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 1325 | 0.120 |
Why?
|
| Renal Circulation | 1 | 2014 | 13 | 0.120 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2014 | 12 | 0.120 |
Why?
|
| Furosemide | 1 | 2014 | 9 | 0.120 |
Why?
|
| Polyethylene Terephthalates | 1 | 2013 | 3 | 0.120 |
Why?
|
| Rifampin | 1 | 2013 | 8 | 0.120 |
Why?
|
| Aneurysm, Infected | 1 | 2013 | 5 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 184 | 0.110 |
Why?
|
| Renal Artery | 1 | 2014 | 47 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 38 | 0.110 |
Why?
|
| Software | 1 | 2014 | 123 | 0.110 |
Why?
|
| Oxygen | 1 | 2014 | 142 | 0.110 |
Why?
|
| Angioplasty | 1 | 2012 | 34 | 0.100 |
Why?
|
| Anesthesia, General | 1 | 2012 | 28 | 0.100 |
Why?
|
| Anesthesia, Conduction | 1 | 2012 | 25 | 0.100 |
Why?
|
| Ischemia | 1 | 2012 | 98 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2015 | 311 | 0.100 |
Why?
|
| Edema | 1 | 2011 | 28 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 322 | 0.090 |
Why?
|
| Second-Look Surgery | 1 | 2010 | 4 | 0.090 |
Why?
|
| Phlebography | 1 | 2010 | 26 | 0.090 |
Why?
|
| Hematoma | 1 | 2010 | 27 | 0.090 |
Why?
|
| Reoperation | 1 | 2011 | 226 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 49 | 0.090 |
Why?
|
| Balloon Occlusion | 1 | 2010 | 36 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2010 | 61 | 0.090 |
Why?
|
| Mesentery | 1 | 2009 | 5 | 0.090 |
Why?
|
| Comorbidity | 3 | 2017 | 566 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1428 | 0.090 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 88 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2010 | 155 | 0.090 |
Why?
|
| Necrosis | 1 | 2009 | 53 | 0.090 |
Why?
|
| Cause of Death | 2 | 2020 | 236 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2020 | 2282 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 3990 | 0.070 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2006 | 2 | 0.070 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 297 | 0.070 |
Why?
|
| Prognosis | 2 | 2020 | 1496 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 448 | 0.060 |
Why?
|
| Registries | 2 | 2017 | 298 | 0.060 |
Why?
|
| Recurrence | 2 | 2016 | 263 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 2263 | 0.060 |
Why?
|
| Child | 1 | 2010 | 2441 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2014 | 97 | 0.060 |
Why?
|
| Logistic Models | 2 | 2017 | 783 | 0.050 |
Why?
|
| United States | 2 | 2020 | 3975 | 0.040 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2017 | 11 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 33 | 0.040 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 143 | 0.040 |
Why?
|
| Survival Rate | 1 | 2020 | 876 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2017 | 68 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2017 | 24 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 1187 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 41 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 46 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 472 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2018 | 494 | 0.030 |
Why?
|
| Community Health Services | 1 | 2015 | 56 | 0.030 |
Why?
|
| Career Choice | 1 | 2015 | 43 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 390 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 400 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 753 | 0.030 |
Why?
|
| Perception | 1 | 2015 | 101 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 989 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2016 | 406 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 667 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 105 | 0.030 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 53 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2014 | 187 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 276 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 132 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1542 | 0.030 |
Why?
|
| North Carolina | 1 | 2017 | 1538 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 9375 | 0.030 |
Why?
|
| Patient Selection | 1 | 2014 | 276 | 0.030 |
Why?
|
| Critical Illness | 1 | 2012 | 88 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 765 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 312 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 560 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 1427 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2006 | 114 | 0.020 |
Why?
|
| Infant | 1 | 2006 | 1061 | 0.010 |
Why?
|